I think the business is strong, but macro is getting worse.
- Our revenue is growing
- Increase in vendors de-risks the business
- Warehouse expansion allows growth
- Recurring software sales is good and opens opportunities too
- Hopefully DAS takes off, not sure who the big players are in the market, but probably lots of competition.
- I'm not sold on the IoT & 5G opportunities, but happy to be wrong
- Dividend is the same 5% (ex FC) as the bank, so need capital growth to offset.
- Forums
- ASX - By Stock
- DDR
- Ann: Q1 FY23 Market Update
Ann: Q1 FY23 Market Update, page-50
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DDR (ASX) to my watchlist
|
|||||
Last
$10.30 |
Change
0.010(0.10%) |
Mkt cap ! $1.856B |
Open | High | Low | Value | Volume |
$10.28 | $10.36 | $10.25 | $107.8K | 10.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 140 | $10.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.30 | 146 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 139 | 10.250 |
2 | 350 | 10.240 |
3 | 476 | 10.230 |
6 | 1813 | 10.220 |
3 | 476 | 10.210 |
Price($) | Vol. | No. |
---|---|---|
10.270 | 257 | 6 |
10.280 | 623 | 7 |
10.290 | 512 | 3 |
10.300 | 2976 | 4 |
10.310 | 1281 | 4 |
Last trade - 10.11am 16/07/2024 (20 minute delay) ? |
Featured News
DDR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online